InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: None

Wednesday, 12/19/2012 7:11:38 PM

Wednesday, December 19, 2012 7:11:38 PM

Post# of 345969
For those of you interested in the clinical trial of Threshold Pharmaceuticals drug TH-302 in previously untreated
pancreatic cancer, here is the presentation made at the ESMO 2012 Congress at the end of September.
http://www.thresholdpharm.com/pdf/borad_et_al_th-302_in_pancreas_cancer_esmo_9-12_with_supplement.pdf

Slide 20 shows the overall survival. Neither treatment arm was statistically different than the gemcitabine arm.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News